Log In
Print
BCIQ
Print
Print this Print this
 

Zomig, zolmitriptan

Also known as: Zomig rapimelt

  Manage Alerts
Collapse Summary General Information
Company AstraZeneca plc
DescriptionSerotonin (5-HT1B) and serotonin (5-HT1D) receptor agonist
Molecular Target Serotonin (5-HT1B) receptor ; Serotonin (5-HT1D) receptor
Mechanism of ActionSerotonin (5-HT1B) receptor agonist; Serotonin (5-HT1D) receptor agonist
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentMarketed
Standard IndicationMigraine
Indication DetailsTreat acute migraine; Treat menstrual migraine; Treat migraine; Treat migraine in adolescents; Treat moderate or severe migraine
Regulatory Designation

Partner

Impax Laboratories Inc.


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today